Teleflex Convenes Urologists in Australia for Summit on Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
January 14, 2020 06:30 ET
|
Teleflex Incorporated
Minimally Invasive UroLift® System Provides Safe and Effective Symptom Relief for Men with an Enlarged Prostate While Preserving Sexual Function* WAYNE, Pa., Jan. 14, 2020 (GLOBE NEWSWIRE) --...
Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
January 07, 2020 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for...
Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate
September 16, 2019 06:45 ET
|
Teleflex Incorporated
WAYNE, Pa., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of an article showcasing the effectiveness and overall benefits of the minimally...
Teleflex Wins New Zealand Innovation Award for UroLift System for Patients with Enlarged Prostate
August 07, 2019 06:45 ET
|
Teleflex Incorporated
Minimally Invasive Treatment Provides Rapid, Durable Symptom Relief Without Compromising Sexual Function* WAYNE, Pa., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today...
Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System
July 09, 2019 06:45 ET
|
Teleflex Incorporated
WAYNE, Pa., July 09, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of positive results from a multi-center study reaffirming the safety and effectiveness...